Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
CTP-543 Novel Therapy Introduced for the Treatment of Alopecia Areata
Concert Pharmaceuticals, Inc introduces CTP-543, Oral Janus kinase inhibitor for the treatment of moderate-to-severe alopecia areata in adult patients....
Talaris Therapeutics Develops Novel Cell Therapy FCR001 for the Treatment of Scleroderma
Novel cell therapy FCR001, was developed by Talaris for the treatment of patients with diffuse systemic sclerosis (SSc), a severe form of the rare autoimmune disease scleroderma....
A Breakthrough Therapy Developed for Investigational Prenatal Treatment ER-004 a Rare Genetic Condition
ER-004, a breakthrough therapy for the prenatal treatment of XLHED, a life-threatening rare genetic condition was developed by EspeRare....
Gvoke HypoPen™ First Autoinjector Discovered for Severe Hypoglycemia
Xeris Pharmaceuticals, Inc discovered novel Gvoke HypoPen™ (glucagon injection),which is used for the treatment of severe hypoglycemia in adults and children with diabetes ages 2 years and above....
GIMOTI™, Novel Nasal Spray Developed for Treatment of Gastroparesisin Adults
GIMOTI™ (metoclopramide), novel nasal spray developed by Evoke Pharma, Inc specifically for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis....
Crysvita - A Breakthrough Therapy Developed For Treatment of TumorInduced Osteomalacia TIO
Crysvita (burosumab-twza) injection the first therapy discovered for the treatment of patients with rare disease, tumor-induced osteomalacia (TIO) corresponding to the age two and older....
Eli Lilly and Company Launched New Rapid Acting Insulin Lyumjev™
Lyumjev™, a new and innovative rapid acting insulin ranging from 100 units/mL and 200 units/mL was launched by Eli Lilly and Company to enhance glycemic control in diabetic patients of type 1 & 2....
A Novel Oral Therapy Discovered to Treat Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Insmed discovered Brensocatib for the treatment of adult patients with Non-cystic Fibrosis Bronchiectasis (NCFBE) for reducing exacerbations. Brensocatib is a novel oral, reversible inhibitor of Dipeptidyl Peptidase 1 (DPP1) for the treatment of bronchiectasis and other inflammatory diseases....
Retevmo™, The First Therapy Developed for Patients with Advanced RET-Driven Lung and Thyroid Cancers
Eli Lilly and Company discovered Retevmo™ (selpercatinib, 40 mg & 80 mg capsules) to treat patients with different types of cancers such as non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancer....
SUNOVION Launches KYNMOBI™ for the Treatment of Parkinson's Disease Off Episodes
Sunovion Pharmaceuticals Inc launched a novel drug KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277) for the acute and intermittent treatment of off episodes in patients with Parkinson’s disease....
